Ignite Creation Date:
2025-12-24 @ 12:37 PM
Ignite Modification Date:
2025-12-27 @ 10:14 PM
Study NCT ID:
NCT01357161
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2011-05-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07-26
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-08
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-18
First Submit QC Date:
None
Study First Post Date:
2011-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-08
Results First Submit QC Date:
None
Results First Post Date:
2017-09-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-31
Last Update Post Date:
2023-09-21
Last Update Post Date Type:
ACTUAL